Cargando…
Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction
Immune checkpoint inhibitors (ICIs) have dramatically enhanced the treatment outcomes for diverse malignancies. Yet, only 15–60% of patients respond significantly. Therefore, accurate responder identification and timely ICI administration are critical issues in tumor ICI therapy. Recent rapid develo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236604/ https://www.ncbi.nlm.nih.gov/pubmed/37268978 http://dx.doi.org/10.1186/s40364-023-00498-1 |